Valkai partners with AbbVie to apply advanced AI in targeted areas of clinical development
Article excerpt
Highlighted: the sentence this signal was extracted from
Published on 09/29/2026 at 21:42 Contact us for any correction request AbbVie has increased its investments in artificial intelligence (AI) by entering into a new collaboration with Valkai to strengthen its integrated AI capabilities across clinical development. As part of this partnership with Valkai, AbbVie will deploy AI capabilities specifically designed to improve efficiency in targeted areas of clinical research, help teams produce analyses more quickly, and foster opportunities to reduce development timelines. This partnership with Valkai builds on the strong foundations established by AbbVie in applying AI to research and development (R&D), thereby helping to increase the scope of data-driven analyses and innovation.
